As announced in the Budget speech 2021-2022, the Government of Mauritius took the first step in the setting up of the Mauritius Institute of Biotechnology Ltd ("MIBL") with a seed capital of around USD 25 million.

The key pieces of legislation governing the authorisation, marketing, sale and supply of pharmaceutical products in Mauritius are the Pharmacy Act 1983 and the Consumer Protection (Price and Supplies Control) Act of 1998.

The key pieces of legislation governing the authorisation, marketing, sale and supply of pharmaceutical products in Mauritius are the Pharmacy Act 1983 and the Consumer Protection (Price and Supplies Control) Act of 1998.